This is in contrast with the observations of Wild-Bode et al. who reported upregulated expression of MMP2 and MT1-MMP, downregulated expression of TIMP-2, and increased invasiveness in glioma cells regardless of PTEN status (Wild-Bode et al., 2001). This evidence concerns the gene PTEN and central nervous system cancer.